Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-2,525
Closed -$270K 371
2022
Q1
$270K Sell
2,525
-230
-8% -$26.4K 0.01% 320
2021
Q4
$420K Buy
2,755
+5
+0.2% +$1.14K 0.02% 238
2021
Q3
$708K Sell
2,750
-1,025
-27% -$295K 0.03% 160
2021
Q2
$1.05M Buy
3,775
+765
+25% +$171K 0.04% 114
2021
Q1
$609K Sell
3,010
-335
-10% -$77.7K 0.03% 179
2020
Q4
$744K Buy
3,345
+160
+5% +$35.9K 0.03% 132
2020
Q3
$686K Sell
3,185
-190
-6% -$39.4K 0.03% 124
2020
Q2
$581K Sell
3,375
-1,625
-33% -$205K 0.03% 132
2020
Q1
$462K Hold
5,000
0.04% 125
2019
Q4
$371K Hold
5,000
0.02% 220
2019
Q3
$310K Sell
5,000
-2,000
-29% -$105K 0.02% 234
2019
Q2
$348K Hold
7,000
0.02% 202
2019
Q1
$363K Sell
7,000
-2,000
-22% -$102K 0.02% 179
2018
Q4
$361K Sell
9,000
-3,150
-26% -$132K 0.03% 148
2018
Q3
$639K Sell
12,150
-48,850
-80% -$2.77M 0.03% 132
2018
Q2
$3.23M Buy
+61,000
New +$3.08M 0.17% 43

Other funds holding DOCU

R.H. Bluestein & Co's DOCU Position: Q2 2022 in Review

R.H. Bluestein & Co sold out of DocuSign (DOCU) in Q2 2022, closing a stake of 2,525 shares — an estimated $270K sold.

R.H. Bluestein & Co first reported a position in DOCU in Q2 2018 and held it in 16 quarters. The position peaked at $3.23M in Q2 2018. 791 funds tracked by Wall St. Rank hold DOCU as of Q2 2022.

  • R.H. Bluestein & Co reported no remaining DocuSign position as of Q2 2022 after selling out during the quarter.
  • R.H. Bluestein & Co sold 2,525 DocuSign shares in Q2 2022, an estimated $270K.
  • R.H. Bluestein & Co first reported a position in DocuSign in Q2 2018 and held it in 16 quarters.
  • R.H. Bluestein & Co's DocuSign position peaked at $3.23M in Q2 2018.
  • 791 funds tracked by Wall St. Rank held DocuSign as of Q2 2022.

Based on R.H. Bluestein & Co's 13F filing for Q2 2022, filed 11 Aug 2022.